Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Tax Rate (2017 - 2025)

Ultragenyx Pharmaceutical (RARE) has disclosed Tax Rate for 9 consecutive years, with 0.68% as the latest value for Q4 2025.

  • On a quarterly basis, Tax Rate rose 36.0% to 0.68% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.7%, a 17.0% decrease, with the full-year FY2025 number at 0.7%, down 17.0% from a year prior.
  • Tax Rate was 0.68% for Q4 2025 at Ultragenyx Pharmaceutical, down from 0.49% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 3.04% in Q4 2023 to a low of 2.63% in Q3 2022.
  • A 5-year average of 0.32% and a median of 0.37% in 2021 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: skyrocketed 222bps in 2023, then tumbled -408bps in 2024.
  • Ultragenyx Pharmaceutical's Tax Rate stood at 0.02% in 2021, then surged by 6005bps to 0.95% in 2022, then soared by 221bps to 3.04% in 2023, then plummeted by -134bps to 1.04% in 2024, then skyrocketed by 35bps to 0.68% in 2025.
  • Per Business Quant, the three most recent readings for RARE's Tax Rate are 0.68% (Q4 2025), 0.49% (Q3 2025), and 0.83% (Q2 2025).